Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Werner Vach

Showing results (21-30 of 297) with videos related to

Pageof 30
Sort By:
Annals of Surgery|July 4, 2019
Comment on "Ethical Issues Across the IDEAL Stages of Surgical Innovation"Franziska J Saxer, Werner Vach
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 25, 2025
Do we need a health technology assessment approach for non-inferiority specifically? A comment on: clinical equivalence and non-inferiority within health technology assessment by Taylor et al. (2025)Beryl Primrose Gladstone, Werner Vach
Journal of General Internal Medicine|May 31, 2018
Design and Interpretation of Noninferiority TrialsWerner Vach, Beryl Primrose Gladstone
BMJ (Clinical Research Ed.)|October 8, 2005
Can risk score models help in reducing serious outcome events in patients with stable angina?Christian Juhl Terkelsen, Werner Vach
Journal of Clinical Epidemiology|January 23, 2013
About half of the noninferiority trials tested superior treatments: a trial-register based studyBeryl Primrose Gladstone, Werner Vach
Plos One|August 1, 2014
Choice of non-inferiority (NI) margins does not protect against degradation of treatment effects on an average--an observational study of registered and published NI trialsBeryl Primrose Gladstone, Werner Vach
Biometrical Journal. Biometrische Zeitschrift|August 15, 2015
A framework to assess the value of application of formal criteria to check clinical relevance in RCTs as part of a benefit assessment strategyWerner Vach, Beryl Primrose Gladstone
Biometrical Journal. Biometrische Zeitschrift|January 24, 2007
Making efficient use of patients in designing phase III trials investigating simultaneously a set of targeted therapies with different targetsWerner Vach, Rene dePont Christensen
Spine|November 4, 2014
Letters. Re: Menke JM. Do manual therapies help low back?Werner Vach, Henrik Wulff Christensen
BMJ (Clinical Research Ed.)|January 22, 2010
Using biomarkers to prioritise patients with stable angina pectoris for bypass surgeryChristian Juhl Terkelsen, Werner Vach
Pageof 30

Showing results (21-30 of 297) with videos related to

Sort By:
Pageof 30
Annals of Surgery|July 4, 2019
Comment on "Ethical Issues Across the IDEAL Stages of Surgical Innovation"Franziska J Saxer, Werner Vach
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 25, 2025
Do we need a health technology assessment approach for non-inferiority specifically? A comment on: clinical equivalence and non-inferiority within health technology assessment by Taylor et al. (2025)Beryl Primrose Gladstone, Werner Vach
Journal of General Internal Medicine|May 31, 2018
Design and Interpretation of Noninferiority TrialsWerner Vach, Beryl Primrose Gladstone
BMJ (Clinical Research Ed.)|October 8, 2005
Can risk score models help in reducing serious outcome events in patients with stable angina?Christian Juhl Terkelsen, Werner Vach
Journal of Clinical Epidemiology|January 23, 2013
About half of the noninferiority trials tested superior treatments: a trial-register based studyBeryl Primrose Gladstone, Werner Vach
Plos One|August 1, 2014
Choice of non-inferiority (NI) margins does not protect against degradation of treatment effects on an average--an observational study of registered and published NI trialsBeryl Primrose Gladstone, Werner Vach
Biometrical Journal. Biometrische Zeitschrift|August 15, 2015
A framework to assess the value of application of formal criteria to check clinical relevance in RCTs as part of a benefit assessment strategyWerner Vach, Beryl Primrose Gladstone
Biometrical Journal. Biometrische Zeitschrift|January 24, 2007
Making efficient use of patients in designing phase III trials investigating simultaneously a set of targeted therapies with different targetsWerner Vach, Rene dePont Christensen
Spine|November 4, 2014
Letters. Re: Menke JM. Do manual therapies help low back?Werner Vach, Henrik Wulff Christensen
BMJ (Clinical Research Ed.)|January 22, 2010
Using biomarkers to prioritise patients with stable angina pectoris for bypass surgeryChristian Juhl Terkelsen, Werner Vach
Pageof 30